To further explore the functional role of integrin αvβ6 in the adhesion of tumour cells to EC, we employed CRISPR/Cas9 technology to establish an ITGB6 knockout (KO) cell line, based on the method outlined previously.26 This evidence concerns the gene ITGB6 and neoplasm.